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Background: Puberty is a critical developmental phase in physical, reproductive and socio-emotional maturation
that is associated with the period of peak onset for psychopathology. Puberty also drives significant changes in
brain development and function. Research to date has focused on gonadarche, driven by the
hypothalamic-pituitary-gonadal axis, and yet increasing evidence suggests that the earlier pubertal stage of
adrenarche, driven by the hypothalamic-pituitary-adrenal axis, may play a critical role in both brain development
and increased risk for disorder. We have established a unique cohort of children who differ in their exposure to
adrenarcheal hormones. This presents a unique opportunity to examine the influence of adrenarcheal timing on
brain structural and functional development, and subsequent health outcomes. The primary objective of the study
is to explore the hypothesis that patterns of structural and functional brain development will mediate the
relationship between adrenarcheal timing and indices of affect, self-regulation, and mental health symptoms
collected across time (and therefore years of development).
Methods/Design: Children were recruited based upon earlier or later timing of adrenarche, from a larger cohort,
with 128 children (68 female; M age 9.51 years) and one of their parents taking part. Children completed brain MRI
structural and functional sequences, provided saliva samples for adrenarcheal hormones and immune biomarkers,
hair for long-term cortisol levels, and completed questionnaires, anthropometric measures and an IQ test. Parents
completed questionnaires reporting on child behaviour, development, health, traumatic events, and parental report
of family environment and parenting style.
Discussion: This study, by examining the neurobiological and behavioural consequences of relatively early and late
exposure to adrenarche, has the potential to significantly impact our understanding of pubertal risk processes.
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The transition from childhood to adolescence is a period
of opportunities (as young people physically and sexually
mature, and peer and familial relationships change),
challenges (as responsibilities and exposure to a range of
risks, such as substance use and sexual activity, in-
crease), and vulnerabilities (with half of all lifetime cases* Correspondence: nba@unimelb.edu.au
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unless otherwise stated.of mental illness starting by age 14 years) [1]. The transi-
tion coincides with the biological processes of puberty
and changes in brain structure and function [2,3]. In-
deed, it is increasingly being recognised that pubertal
maturation may influence brain development, and in
turn, psychosocial maturation. In this regard, the timing
of pubertal stage relative to peers is relevant. Early pu-
bertal timing predicts adolescent onset mental illness
and other poor outcomes during adolescence, and in
some cases better accounts for sex differences in the on-
set of psychopathology than age [4,5]. Specifically, early
pubertal timing has been consistently associated withal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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boys are mixed [8]. Further, advancing pubertal stage in-
creases risk for both the onset and persistence of depres-
sive symptoms in girls [9] and violent and anti-social
behaviours in both sexes [10].
The current literature on puberty and brain devel-
opment has many general methodological limitations
[see 11], and specifically has not addressed the differen-
tial effects of adrenarche (the earlier phase of pubertal de-
velopment driven by the hypothalamic-pituitary-adrenal
[HPA] axis) and gonadarche (the later phase driven by the
hypothalamic-pituitary-gonadal [HPG] axis). Despite the
fact that the timing of both phases of pubertal develop-
ment have been associated with behavioural and mental
health problems [6,7,12], most research has focused on
gonadarche and little is known about the earlier adrenal
phase of pubertal development. This emphasis has likely
been a product of the relative difficulty in assessing adre-
narcheal development due to the paucity of early physical
signs, and that adrenarche has only been detected in
humans and some higher primates [13], limiting experi-
mental animal work.
This paper is a methodological description of the Imaging
brain development in the Childhood to Adolescence
Transition Study (iCATS), which was embedded in a
larger Childhood to Adolescence Transition Study (CATS)
[14]. Both of these studies aim to address existing gaps in
knowledge. However, iCATS will specifically, and uniquely,
examine the influence of adrenarcheal timing on brain
development and function, and on mental health.
Puberty and adolescent brain development
The principal focus in studies of adolescent brain develop-
ment was traditionally on age-related changes [e.g., 15].
Based on findings (e.g., peaks in grey matter density that
appear to coincide with timing of puberty onset, [16])
researchers have more recently suggested that brain devel-
opment patterns align better with pubertal changes rather
than with age. It is well established that steroid hormones
play critical roles in development [17]. However, the ex-
tant literature remains sparse, and predominantly focuses
on gonadarcheal indices. Importantly, although there is
informative animal work regarding the links between
gonadarcheal hormones and brain structure and function,
relatively little is known about this relationship in
humans [16] and particularly in relation to adrenarcheal
hormones [18].
Recently, a small number of adolescent MRI studies
have investigated, in more detail, the relationships
among brain structure and function, gender, and hor-
mones that change at puberty. A structural MRI study
by Peper and colleagues [19] with 10–15 year olds
showed an association between testosterone levels and
global grey matter density in males (and not in females).Neufang and colleagues [20] examined 46 participants
aged 8–15 years and found a positive relationship be-
tween Tanner stage and testosterone levels and grey
matter volume in the amygdala, and a negative relation-
ship between these measures and hippocampal volume,
regardless of gender. In addition, males showed a nega-
tive relationship between testosterone and parietal cor-
tex grey matter. In a more recent study specifically
examining adrenarcheal hormones, Nguyen et al. [21]
explored associations between androgens and cortical
thickness and found that DHEA levels were positively
associated with cortical thickness in various frontal, par-
ietal, and temporal cortical regions from various ages be-
tween 4–13 years. For instance, DHEA was positively
associated with cortical thickness of the left dorsolateral
prefrontal cortex from ages 4 to 8 for males and females.
Conversely, sex-specific changes were observed in the
association between testosterone and cortical thickness.
Specifically, pre-pubertal males (defined as Tanner Stage
1 or 2) typically demonstrated negative associations be-
tween testosterone and cortical thickness, whereas pre-
pubertal females demonstrated positive associations.
Trajectories of white matter development have also been
found to differ as a function of pubertal hormones.
Peper and colleagues (2009) reported a positive associ-
ation between gonadotropic hormones and white matter
density at age nine. A study by Perrin and colleagues
[22] found that trajectories of white matter development
in males were related to expression levels of a gene en-
coding a testosterone receptor, suggesting that effects of
testosterone may be responsible for the sexually di-
morphic relationship between age and white matter vol-
ume. These studies demonstrate promising evidence that
pubertal hormones influence structural brain develop-
ment in humans.
Few studies have investigated the effects of puberty on
brain function in normal samples. Forbes and colleagues
[23] found that those with more advanced pubertal mat-
uration (measured by Tanner stage) exhibited less stri-
atal and more medial prefrontal reactivity to reward, and
that testosterone was positively correlated with striatal
reactivity in boys during reward anticipation and nega-
tively correlated with striatal reactivity in girls and boys
during reward outcome.
Importantly, these published studies have not investi-
gated possible effects of the timing of pubertal events on
brain development, highlighted as a critical area for fu-
ture investigation [16]. We have recently completed the
first study of the relationship between pubertal timing,
brain structure and depressive symptoms during early
adolescence [24]. We found that larger volume of the pi-
tuitary gland, a key component of the HPG and HPA
axes, mediated the relationship between early pubertal
timing and depressive symptoms in 155 adolescents
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ume in early adolescence predicts HPA activity in mid-
adolescence in the same cohort [25]. These findings are
consistent with neurobiological mechanisms being re-
sponsible for the link between early pubertal timing and
depressive symptoms in adolescents.
However, as these studies only used self- and parent-
report measures of pubertal development and did not
differentiate adrenarche and gonadarche, they cannot
differentiate the relationship between specific adrenarch-
eal hormones, brain development and function. Further-
more, the focus on one brain region (the pituitary
gland), although important, did not allow investigation
of the role of brain development more broadly in these
processes.
Imaging brain development in the Childhood to
Adolescence Transition Study (iCATS)
Funding was obtained from the Australian Research
Council (ARC; DP120101402, 2012 – 2014) to recruit
two groups of participants stratified by hormonal indices
of pubertal timing, selected from the larger population-
based CATS investigation (N = 1239 Grade 3 [667 females;
7.79 – 10.65 years of age]) [14]. This permitted the investi-
gation of the associations between the timing of pubertal
maturation (as assessed by gender-specific hormonal and
body morphological changes) during early pubertal de-
velopment, namely adrenarche (funded) and gonadarche
(to be funded), on aspects of brain structure and func-
tion implicated in emotional dysregulation and mental
disorder.
Aims
The broad aim of iCATS is to elucidate which children
are most at risk for adverse outcomes as they pass
through puberty. The specific aim of iCATS is to identify
the neurobiological mechanisms that mediate this risk.
The primary objective of this study is to explore the hy-
pothesis that patterns of structural and functional brain
development will mediate the relationship between pu-
bertal timing and the indices of affect, self-regulation,
and mental health symptoms collected across waves
(and therefore years of development).
Current understanding of the relationship between pu-
berty and brain development is rudimentary, with few
studies looking specifically at the effects of pubertal tim-
ing [24]. We hypothesise, based on extant literature, that
earlier exposure to adrenarche will be associated with
neurodevelopmental and behavioral outcomes that have
been previously associated with greater risk for mental
health problems. Our specific aims are to:
1. Investigate the relationship between adrenarcheal
timing and brain structure in both sexes, byexamining associations between advanced
adrenarcheal development, measured by DHEA,
DHEA-S and testosterone, and (i) cortical grey
matter, (ii) white matter, (iii) limbic, and (iv) striatal
volumes.
2. Investigate the relationship between adrenarcheal
timing and brain function (both at rest and in the
context of affective processing) in both sexes, by
examining associations between advanced
adrenarcheal development and both function and
connectivity in (i) limbic, (ii) prefrontal, and (iii)
parietal regions.
3. Investigate if (i) stressful life events, (ii) long-term
cortisol levels and (iii) immune system function
moderate the associations between adrenarche and
brain structure and function described in Aims 1
and 2.
4. Investigate the relationship between Aims 1 – 3,
health and risk, by examining whether the patterns
of structural and functional brain changes identified
above mediate the relationship between pubertal
development and indices of affect, self-regulation,
and mental health symptoms.
Methods/Design
Design
The funded component of iCATS is a cross-sectional
study of the relationship between pubertal timing and
brain structure and function in children approximately
9 years old. At this time the processes of adrenarche are at
the fore. Children were selected and invited to take part in
iCATS based upon hormone levels collected at a baseline
assessment from the broader CATS [14] (M age = 8.98,
SD = 0.39 years). Children were grouped as either rela-
tively early adrenarche or late adrenarche, based upon the
entire distribution (see Selection Strategy below). Children
took part in iCATS an average of 27.78 weeks (SD = 8.45)
after their CATS participation. iCATS is based in the
Melbourne School of Psychological Sciences at the
University of Melbourne, Australia. Ethics approval was
granted by the Royal Children’s Hospital Human Research
Ethics Committee (#32171), and ratified by the University
of Melbourne Human Research Ethics Office (#1238745).
Further funding will be sought to enable the current
investigation to be repeated in later years, allowing
examination of latter adrenarcheal and gonadarcheal
processes, as well as longitudinal and prospective re-
lationships with brain development and function and
health outcomes.
Recruitment
Recruitment was restricted to the CATS cohort [see 14],
and only to those families with active consent who had
taken part in all CATS baseline assessments. The
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pant information and consent (PICF) documents by
post, and followed up with a phone call at least seven
days later. Parents were given the option to decline con-
tact (and thus participation) via email, phone or mobile
phone text message. School principals were notified and
informed about the study two weeks prior to PICF docu-
ments being sent to families, and teachers one week
prior. Children attending schools and/or with parents
who were identified by CATS staff as reticent about par-
ticipation were not invited to take part in iCATS (N = 94
of total CATS cohort). However, their hormonal data
was left in the total distribution calculations (see below).
Selection strategy
Participants were characterised, based upon stratification
of their relative pubertal development in the CATS base-
line assessment, into two groups: (1) a relatively early
adrenarcheal group, and (2) a relatively late adrenarcheal
group. Measuring pubertal development, i.e. progress in
adrenarche, in children of this age remains an area of
conjecture; particularly as few, if any, physical signs of
development are detectable [11,26]. Therefore, as the
primary aim of iCATS was to examine the effect of adre-
narche on brain development, and the hypothesised
mechanism of action is via hormones, adrenarcheal hor-
mones (i.e. DHEA, DHEA-S, and testosterone) were
assessed in order to inform the selection of groups. There
was a high degree of correlation between DHEA and tes-
tosterone in the larger cohort (males: r = .69, p = .000; fe-
males: r = .65, p = .000), and previous work has established
that DHEA and testosterone levels show strong corres-
pondence with physical examinations and a picture based
interview at Tanner stages I – V [26].
Although testosterone is typically associated with
gonadarche, it is also metabolized in the adrenal zona
reticularis and peripheral tissue after the conversion of
DHEA to androstenedione [27,28]. Notably, these non-
gonadal pathways are the primary source of testosterone
in males and females pre-gonadarche, and females post
gonadarche. Therefore, children with relatively advanced
adrenarche will demonstrate high DHEA and testoster-
one levels, and those with relatively delayed adrenarche
will show low levels of DHEA and testosterone. Adre-
narche was therefore modeled here by plotting DHEA
and testosterone hormone levels from the baseline
CATS saliva collection, with the crossover area of the
upper tertiles of DHEA/testosterone characterised as
relatively earlier development (ED), and the lower ter-
tiles as relatively later development (LD). Group allo-
cation will be re-examined with the iCATS hormone
and parent report data collected (see below). Inclu-
sions applied prior to this modeling were an age be-
tween 8 and 10 years, and a BMI between the 5th and95th percentiles of standardised growth for children
and adolescents [29].
Participants
Participants comprise 128 children (M age = 9.51 years,
SD = 0.36) and a parent/guardian (84% were mothers),
with 66 children (35 female) participating from the ED
group, and 62 (33 female) from the LD group. A total of
377 families were invited to take part, however 241
declined to participate and a further 8 were excluded
based upon eligibility criteria (see Table 1).
Data collection
Participating families were visited at home, and then
asked to attend a session at The Royal Children’s
Hospital (RCH) in Melbourne, Australia.
Home visit
The home visit initially comprised a review of study par-
ticipation requirements, eligibility, PICF documents, and
MRI familiarization video, as well as questions from the
family. Families were informed that participation in
iCATS had no bearing on participation in the larger
study, and that they were free to complete some compo-
nents and not others. Families were advised that all their
information is confidential, except where limited by law,
and that information collected will not be fed back to
them, except where clinically significant abnormalities
were indicated. Signed consent from a parent/guardian
and verbal consent from children was required.
Measures collected during the home visit included
demographic and MRI safety information, anthropomet-
ric measures, parent questionnaires, and the collection
of a hair sample from the child. Further, the procedure
for the collection of the saliva samples on the day of,
and day prior to, the RCH visit were explained and
demonstrated.
RCH Visit
Visit requirements and consent was reviewed, and chil-
dren asked to complete questionnaires. Research staff
reviewed children’s responses to questionnaires and any
indications of risk or clinically significant pathology were
followed up with investigators (at the time or later,
dependent on level of risk), and parents and children
as appropriate. Children and parents were then run
through an MRI scanner familiarisation session, to de-
crease anxiety, increase participation rates and compliance/
stillness during the scans. All research staff administering
the familiarisation sessions were required to undergo
training at RCH through the Developmental Imaging
Group of MCRI.
An MRI technician at RCH verbally reviewed the MRI
safety checklist with parents and children just prior to
Table 1 Eligibility criteria for iCATS
Inclusion Criteria Exclusion Criteria
Parental and child consent in CATS; History of head trauma or loss of consciousness;
Completed Wave 1 of CATS in full, i.e., parent/guardian q’s, and child q’s,
anthropometric measurements, and saliva sample;
History of clinically significant developmental
or intellectual disorder;
Child aged between 8.5 and 9.5 years at the time of their CATSparticipation; Clinically significant DHEA, DHEA-S, Testosterone;
Written consent provided by parent for their own participation; Indications of claustrophobia;
Written consent provided by the parent and the child for the child’s participation; and, Long-term use of steroidal or amphetamine
based medications;
Verbal consent provided by the child. Short-term current use (i.e., < 2 weeks) of amphetamines;
Short-term current use of steroidal medications
will be reviewed on a case-by-case basis;
Presence or likelihood of internal or external
non-removable ferrous metals;
Inability or unwillingness of participant or parent/guardian
to provide informed consent.
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to choose a cartoon or movie they would like to watch
during the scans (excluding the fMRI sequences). Parents
were asked to remain in the MRI room while scanning
was carried out. Subsequently, children were positioned
comfortably in a supine orientation with their head
located in a head-RF coil that was electrically isolated. The
participant viewed a screen, via an angled adjustable mir-
ror, on which all visual stimuli or video were presented
using a back-projection system attached to a computer.
Children wore MR-compatible headphones to reduce
MRI noise, to allow them to hear instructions and speak
with the MRI technician, and to hear the audio of any car-
toons or movies they watched. Children were provided
with an “Emergency Stop” button, in order to indicate to
research staff if at any stage during the scan they felt dis-
tress and wanted to cease the procedure. Children com-
pleted a T1-weighted MPRAGE structural sequence,
followed by two fMRI sequences (rest [eyes closed], and
an affective faces task), and finally a diffusion weighted
imaging sequence.
In cases where technical error or movement required
a particular sequence be repeated, a case-by-case assess-
ment was made by research staff in discussion with the
parent, child and MRI technician. Scanning took an
average of 45 minutes.
After the scan families were given a break and then
children completed the intelligence quotient (IQ) test.
Finally, parents and children took part in a debriefing
interview.
Measures
Demographics and health information
Detailed demographic information was collected as part
of the larger study [14], including family composition,
parental education and age, annual household income,language spoken at home, ethnicity and adoption, and
this data will be available for iCATS analyses. However,
critical information was checked with parent and child,
including names, dates of birth, and contact details.
Questions were also asked covering health information
related to eligibility criteria and MRI safety exclusions,
as well as illnesses and stressful events experienced in
the prior three months.
Magnetic resonance imaging
Neuroimaging data were acquired on the 3T Siemens
TIM Trio scanner (Siemens, Erlangen, Germany) at the
MCRI, RCH, Melbourne. Participants lay supine with
their head supported in a 32-channel head coil.
Structural scan T1-weighted images were acquired dur-
ing a 3.5 minute sequence (repetition time = 1900 msec;
echo time = 2.24 msec; flip angle = 9°, field of view =
23 cm2), which produced 176 contiguous 0.9 mm thick
slices (voxel dimensions = 0.9 mm3).
DWI Two diffusion weighted sequences were included
in the protocol. The first sequence was optimised for
generation for diffusivity maps (60 directions; b = 1000 s/
mm2, repetition time = 8800 msec; echo time = 99 msec;
slices = 64; voxels = 2 x 2 x 2). The second diffusion se-
quence was optimised for tractography (HARDI: 67 direc-
tions; b = 3000 s/mm2; repetition time = 8100 msec; echo
time = 113 msec; slices = 54, voxels = 2.3 x 2.3 x 2.3).
Resting fMRI A single 6-minute continuous functional
gradient-recalled acquisition sequence was conducted at
rest to acquire 154 whole-brain T2*-weighted echo-
planar images (repetition time = 2400 ms, echo time =
35 ms, pulse angle = 90°) within a field of view of
126 mm, with a voxel size of 3.3 × 3.3 × 3.3 mm. Thirty-
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maps were obtained in order to correct for distortion
caused by magnetic field inhomogeneities.
Passive face viewing fMRI task Participants were ad-
ministered a modified version of a common face
emotion-viewing task used previously with children [30].
As in these prior studies, children were presented with a
series of faces varying in affective content and asked to
complete a simple button press each time a face ap-
peared (to ensure maintenance of attention). A less con-
strained response than other typical affective face
paradigms was chosen given the young age of our child
participants. Calm, happy, angry, and fearful facial ex-
pressions from the Nimstim Set of Facial Expressions
(NimStim; http://www.macbrain.org/resources.htm) were
presented in two 3 minute 40 second runs using a block
design. Each run contained 1 block of each face type, with
each containing 8 faces (randomly presented, 4 male and
4 female) presented for 3 seconds each, separated by a
1 second fixation. Blocks were separated by 15 second fix-
ation rests. Given the high percentage of Caucasian partic-
ipants, and the predominant use of Caucasian faces in
Australian face-processing research, only Caucasian faces
were used in the paradigm. Block order was counterba-
lanced across participants. During each run, 70 whole-
brain T2*-weighted echo-planar images (repetition time =
3000 ms, echo time = 40 ms, pulse angle = 85°) within a
field of view of 120 mm, with a voxel size of 3 × 3 ×
3 mm. Forty interleaved slices were acquired.
Saliva samples
Children, with the help of a parent/guardian, were asked
to collect a saliva sample on the day of and day prior to
their RCH visit immediately after waking, and prior to
the consumption of food or tooth brushing. This was
collected via the passive drool of whole saliva using a
straw into test tubes (all equipment provided). Families
were given a stopwatch to allow them to record how
long it took the child to provide enough saliva to reach
the marked 2.5 ml line on the tube. Samples were then
frozen in family’s freezers in provided sealed containers,
and subsequently transported in provided coolers packed
in Techni-IceTM to RCH on the day of the MRI visit.
Families were asked to minimize the time the samples
spent out of the freezer, and no samples were found to
have risen above 0°C upon arrival at RCH. Samples were
then assayed an average of 7.72 weeks (SD = 4.84) after
collection, with one freeze/thaw cycle. At time of assay,
samples were defrosted and centrifuged, with the super-
natant assayed for levels of testosterone, DHEA and
DHEA-S, as hormonal markers of adrenarcheal develop-
ment. Remaining supernatant was stored in 1 ml ali-
quots in a -80C freezer for future assays. An aliquot wassubsequently assayed for immune system biomarkers, in-
cluding C-reactive protein (CRP) and secretory immuno-
globulin A (SIgA). Salivary assays of each of these
biomarkers are now well-accepted substitutes for meas-
uring serum levels [31,32], although there are methodo-
logical idiosyncrasies for each. For example, DHEA-S
must pass between cells to be excreted in saliva and thus
salivary flow rate is an important determinant of the
index. Hormonal assays were conducted at MCRI, using
Salimetrics ELISA kits. Kits from the same lot numbers
were used, as were in-house controls. The inter-assay
coefficients of variation (CVs) were: DHEA = 5.45%,
DHEA-S = 7.53%, testosterone = 13.54%. The intra-assay
CVs were: DHEA = 8.56%, DHEA-S = 9.38%, testoster-
one = 7.32%.Hair sample
Hair samples were collected for the assay of long term
cortisol levels. Cortisol levels are most commonly
assessed via saliva, urine and serum collections. How-
ever, variable findings in the cortisol/stress literature
may be due to methodological differences in the timing,
number and type of cortisol measures taken, likely due
to circadian cycling, and high intra-individual variability
and reactivity. Hair, a relatively new measure of cortisol,
which although unable to demonstrate HPA reactivity
temporally linked to a short term stressor, is able to pro-
vide a reliable indicator of long term HPA function
[in the order of months, 33]. Hair grows at approxi-
mately 1 cm per month, thus 3 cm lengths of hair will
provide an index of cortisol over the preceding three
months. Samples were collected from an area approxi-
mately 1 cm2 on the posterior vertex of the scalp, as this
has proven the most reliable area for stable cortisol
levels. Hair samples were not collected where <3 cm of
hair length was available, to minimize cosmetic impact,
therefore significantly fewer boys provided these sam-
ples. Hair cortisol assays were conducted by Stratech
Scientific, where samples were cut down to 3 cm
lengths, and processed and assayed as described previ-
ously [34], using Salimetrics ELISA cortisol kits. The
inter-assay coefficient of variation (CV) was 6.7%, and
intra-assay CV 4.9%.Anthropometry
Two measurements were obtained for height, weight
and waist circumference. A third measurement was ob-
tained where the prior two were not within a specified
range (0.5 cm for height, 0.1 kg for weight, 0.5 cm for
waist). The mean value was used in any further calcula-
tions if two measurements were taken, and the median
value was used if three measurements were obtained.
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able rigid Invicta stadiometer. Height was transformed to
z-scores based upon age and gender related reference
charts [35].Weight Was measured to the nearest 0.1 kg using cali-
brated Tanita THD 382 digital scales. Children were asked
to remove shoes, coats and heavy clothing items. Body
Mass Index (kg/m2) was calculated and transformed,
along with student weight, to z-scores based upon age and
gender related reference charts [35].Waist circumference Was measured with a non-stretch
anthropometric tape according to the International Society
for the Advancement of Kinanthropometry (ISAK) proto-
cols. Waist circumference is an acceptable, non-invasive
and reliable indicator of intra-abdominal fat and was mea-
sured to the nearest 0.1 cm [36].Parent questionnaires
Questionnaires completed by parents/guardians comprised
reports on child, and self-report. The broad domains ques-
tionnaires fall into are child pubertal development,
internalising-externalising behaviour, and traumatic events,
as well as, parental report on the family environment and
parenting style.The Pubertal Development Scale Parent Report (PDS-
PR) is a non-invasive questionnaire measure of pubertal
development, and is based on the scale of Petersen and
colleagues [37]. The version used is completed by par-
ents, and for female children comprises nine items (in-
cluding date of onset for menarche, if applicable), and
for male children comprises 11 items. The PDS-PR has
been demonstrated to be both a valid and reliable meas-
ure of pubertal development in children, showing high
levels of consistency with other more direct measures of
development [26,38].The Sexual Maturity Status Parent Report (SMS-PR) is
a series of stylised line drawings of girls/boys bodies at
differing stages of pubertal development [39]. Parents
with a female child are asked to look at a page with five
stages of breast development, and five stages of hip and
pubic hair development, and asked to circle a number
above the two images that most accurately represent
their daughter’s development. Parents with a male child
complete the same task, but with five stages of male
genital and pubic hair development in the one set of five
images. These images directly correspond to the Tanner
stages of pubertal development, and have shown good
reliability with physician ratings [11].The Child Behaviour Checklist Parent Report (CBCL-
PR) is a parent/guardian questionnaire in which a child's
problem behaviours and competencies are rated, with a
focus on internalising and externalising behaviours [40].
The age range for children is 6 – 18 years and it provides
empirically based syndromes scales scored from factor
analyses including Anxious/Depressed, Withdrawn/De-
pressed, Somatic Complaints, Social Problems, Thought
Problems, Attention Problems, Rule-Breaking Behaviour,
and Aggressive Behaviour. The CBCL also provides
DSM-IV scales, including Affective Problems, Anxiety
Problems, Somatic Problems, Attention Deficit/Hyper-
activity Problems, Oppositional Defiant Problems, and
Conduct Problems. The CBCL has a comprehensive
normative sample across ethnicities and SES [40].
The Lifetime Incidence of Traumatic Events Parent
Report (LITE-PR) is a checklist covering aspects of a
child’s history of potentially traumatic events. The
checklist, devised by Greenwald and Rubin [41], allows
parents to rate which types of traumas or losses their
child has experienced, at what age, how many times,
how upset the child was at that time, and how much it
bothers them currently. Items can be classified into cat-
egories: accidents, witnessing an injury to a loved one,
bereavement, natural disasters, abuse (both physical, sex-
ual and emotional), witnessing domestic violence and
being a victim of crime. The 16 item LITE was adapted
here, by removing the items on sexual assault, and add-
ing two new items covering mother-child separations
and domestic relocation. The LITE was designed as a
screener, and thus no agreed scoring system has been
developed. For the purposes of the present investigation
each item will be tallied to give a score for the total
number of types of trauma, and another score for the
overall number of traumas experienced. The level of
upset/bother caused by each type of trauma indicated will
also be scored (e.g., 0 = none, 1 = some, 2 = lots) and tal-
lied to give a score for the level of emotional upset experi-
enced when the trauma occurred, and how much it
bothers them now.
The Alabama Parenting Questionnaire (APQ) Mea-
sures five dimensions of parenting that are relevant to
the aetiology and treatment of child externalising and
internalising problems: (1) positive involvement with
children, (2) supervision and monitoring, (3) use of posi-
tive discipline techniques, (4) consistency in the use of
such discipline and (5) use of corporal punishment [42].
Factor analyses have substantiated the five factor sub-
scales [43], and the questionnaire has been utilised and
published widely with a range of populations. The APQ
has normative data in the relevant age range, as well
good evidence for reliability and validity [44].
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Parent Report (MNBS-PR) was developed to estimate
the prevalence of neglect and specific sub-types of neg-
lect in community samples, with differing versions for
different age probands [45,46]. The MNBS for 5 – 9 year
olds was used to measure the extent to which the fol-
lowing needs of children are or have been neglected:
physical needs such as food, clothing, shelter, medical
care; emotional needs such as affection, companionship,
support; supervision needs such as limit setting, attend-
ing to misbehaviour, knowing child's whereabouts and
friends; and, cognitive needs such as being played with
or read to, assisting with school homework versions
measure the following four aspects of neglect. Parents
were asked to consider the past six months and report
on each item. Adequate levels of reliability and validity
have been reported [46].
Child questionnaires
The Children’s Depression Inventory 2 (CDI-2) Is a
brief self-report test that helps assess cognitive, affective
and behavioural signs of depression in children and ado-
lescents 7 to 17 years old. The CDI-2 has two scales
(Emotional Problems, Functional Problems) and four
subscales (Negative Mood/Physical Symptoms, Negative
Self-Esteem, Interpersonal Problems, Ineffectiveness).
The CDI-2 has normative data in the relevant age range,
as well solid evidence for reliability and validity [47].
The Spence Children’s Anxiety Scale (SCAS) Is a brief
self-report test of anxiety symptoms broadly in line with
the dimensions of anxiety disorder proposed by the
DSM-IV. The scale assesses six domains of anxiety in-
cluding generalized anxiety, panic/agoraphobia, social
phobia, separation anxiety, obsessive-compulsive dis-
order and physical injury fears. The SCAS has normative
data in the relevant age range, as well solid evidence for
reliability and validity [48,49].
Positive Affect and Negative Affect Schedule Child
Form (PANAS-C) is a self-report questionnaire used to
measure the respondent’s emotions. The state and trait
forms of the questionnaire was used, indexing emotions
for “right now” and during “the past few weeks”, respect-
ively. It lists single commonly used adjectives (e.g., Inter-
ested, Sad, Frightened, Alert), and items are grouped
into subscales: positive affect and negative affect. The re-
spondent is asked to read words that describe feelings
and emotions and enter a number that corresponds to
the value on a scale. The 5-item scale ranges from “not
at all”, with a value of 1, to “a lot” with a value of 5. The
PANAS-C has been used successfully on large studies ofchildren and exhibits high reliability and good conver-
gent and discriminant validity [50].
Edinburgh Handedness Inventory (EHI) Can be ad-
ministered as an interview, observational assessment or
self-report questionnaire to establish the dominant hand
[51]. Items consist of a series of activities, and partici-
pants are asked to indicate their hand preference for
each. The EHI is completed in the current study as an
observational interview, where children are asked to
mimic the activity described. This decreases self-report
perceived dominant hand bias. The handedness prefer-
ence score is used in the analysis and interpretation of
MRI data and the examination of laterality effects.
Intelligence quotient test
The Wechsler Abbreviated Scale of Intelligence (WASI)
is a standardized brief measure of general intelligence.
Children completed the two-subtest form, comprising
Vocabulary and Matrix Reasoning, which provides an es-
timate of Full Scale IQ (FSIQ) and only takes 15 minutes
to complete. Norms are based on a national U.S.A. co-
hort of 2300 participants between the ages of 6 and
90 years.
Sample size
Using G*Power 3.1.5 [52], power analyses reveal that
120 participants will be sufficient to achieve power equal
to at least 80% for standardized moderating effects of at
least 0.26 between continuous variables (equivalent to an
improvement in R-squared for the moderating term of
0.07) when α = .05. The same sample size is sufficient to
achieve power equal to at least 80% for moderate or lar-
ger mediating effects (i.e., a standardized effect of about
0.39) where the independent variable to mediator, and
mediator to dependent variable relations are of medium
sizes (i.e., standardized regression paths of 0.26 − 0.39)
[53]. Results reported in analogous published studies of
brain structure and functioning in pubertal development
have all reported much larger effect sizes with smaller
sample sizes [e.g., 23, 24], thereby indicating that the
current study has appropriate statistical power given
current standing of knowledge in this area.
Data analysis
The primary method of analysis for all four aims of the
study will be multiple linear regression. The dependent
variable for aims 1 – 3 will be the relevant brain struc-
ture measure or activation measure referred to in the
hypothesis. The dependent variables for aim 4 will be
the collected indices of affect, self-regulation, and mental
health symptoms. Both whole brain and region of inter-
est (ROI) analyses will be conducted using FreeSurfer
and SMP8 software for brain grey matter structure and
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tional measures will be extracted from ROIs defined ei-
ther anatomically or based on the findings from aims 1–
2. The MRtrix package (JRD Tournier, Brain Research
Institute, Melbourne, Australia, http://www.brain.org.au/
software/) will be used to perform white matter tracto-
graphy with diffusion weighted MRI, resolving crossing
fibres using Constrained Spherical Deconvolution [54].
Hypotheses 3 – 4 will be investigated using linear re-
gression models and bias-estimated bootstrapping tech-
niques to test for moderated mediation.Discussion
There are good reasons to suspect that pubertal hormo-
nal changes affecting cognitive and affective systems in
the brain, and the resultant psychological changes, most
powerfully explain the emergence of symptoms of men-
tal disorder. However the extant human literature on the
relationship between pubertal processes and brain devel-
opment is preliminary at best, and often confounds as-
pects of pubertal development such as stage, timing and
chronological age. Furthermore, although adrenarche
and gonadarche are clearly distinct phases of pubertal
development, with differing underlying biological mech-
anisms, their differential impacts on brain development
have not yet been examined in a comprehensive study.
Compared to other phases of development, puberty and
its disorders remain unexplored and poorly understood.
This study, by examining the neurobiological and behav-
ioural consequences of relatively early and late exposure
to adrenarche, has the potential to profoundly change
our understanding of pubertal risk processes. Work on
preventive interventions suggests the feasibility of inter-
vening in the social contexts of younger adolescents, but
the further development of such interventions is now
limited by our understanding of how puberty interacts
with the social context and lifestyles of young people to
generate health problems.Abbreviations
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